orphenadrine has been researched along with Afferent Pupillary Defect in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PEMBERTON, JW | 1 |
| BROWN, DJ | 1 |
1 other study available for orphenadrine and Afferent Pupillary Defect
| Article | Year |
|---|---|
Accommodative convergence. A study of the effect on the AC/A ratio of partial cycloplegia induced by systemic medication (orphenadrine citrate).
Topics: Accommodation, Ocular; Humans; Orphenadrine; Parasympatholytics; Pupil Disorders | 1962 |